awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37220742-587410A2-6B5E-4D47-AC4B-57FB31A7C049
Q37220742-587410A2-6B5E-4D47-AC4B-57FB31A7C049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37220742-587410A2-6B5E-4D47-AC4B-57FB31A7C049
Targeting T cells with bispecific antibodies for cancer therapy
P2860
Q37220742-587410A2-6B5E-4D47-AC4B-57FB31A7C049
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37220742-587410A2-6B5E-4D47-AC4B-57FB31A7C049
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eac081856e255416340604dc978b9b404fc02abf
P2860
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.